HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.
HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.
复制标题
DOI:
10.1371/journal.pone.0068656
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Yu XF
中科院分区:
文献类型:
--
作者:
Qi H;Zhao K;Xu F;Zhang X;Zhang Z;Yang L;Li C;Liang X;Guo W;Chen S;Liu Z;Zhang W;Yu XF
HIV-1 prevalence in Guangxi, China, has been growing since 1996, when the first case was reported. Over half of HIV-1 positive patients in Guangxi Province were injecting drug users (IDUs), possibly because of the province’s location near drug-trafficking routes. Since a phase II HIV vaccine trial is ongoing there, a current characterization of the subtypes of HIV-1 among IDUs in Guangxi would provide critical information for future HIV vaccine trials, as well as further control and prevention of HIV-1 transmission. Thus, we conducted a molecular epidemiological investigation of HIV-1 samples from 2008–2010 among IDUs in multiple cities in Guangxi Province. Our results, based on the gag/pol fragment, indicated a very high proportion (78.47%) of HIV-1 CRF08_BC recombinants, some CRF01_AE (15.38%) recombinants, and a low proportion of CRF07_BC (6.15%) recombinants among the IDUs. The high proportion of CRF08 HIV-1 strains among recent IDUs matches the vaccine candidate constructs. However, future vaccine development should also incorporate CRF01-targeted vaccine candidates. Distinct Env sequence evolution patterns were observed for CRF08_BC and CRF01_AE, indicating that different local selection pressures have been exerted on these two HIV-1 subtypes. Unique drug-resistant mutations were also detected, and our data indicate that HIV treatment programs should consider pre-existing drug-resistant mutations.
登录
查看更多内容
影响因子:
3.7
作者:
Shang H;Zhong P;Liu J;Han X;Dai D;Zhang M;Zhao K;Xu R;Yu XF
通讯作者:
Yu XF
影响因子:
11.8
作者:
Garten, RJ;Zhang, JB;Yu, XF
通讯作者:
Yu, XF
影响因子:
3.8
作者:
Pang, Wei;Zhang, Chiyu;Zheng, Yong-Tang
通讯作者:
Zheng, Yong-Tang
影响因子:
--
作者:
Teng, T;Shao, Y
通讯作者:
Shao, Y
影响因子:
3.7
作者:
Liu J;Zhang C
通讯作者:
Zhang C